Replacement Secretory Glands

Researchers have engineered functional, lab-grown precursors to salivary and tear glands, successfully connecting them to ducts and nerves in mice.

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Bioengineered salivary gland (green, GFP-epithelial cells and TRITC-gelatin-injected)TSUJI ET AL.A team led by investigators at the Tokyo University of Science (TUS) has created precursors to salivary and lacrimal glands that, when transplanted into mice, successfully connected to the host ducts and nervous system. Once connected, these lab-grown secretory glands helped to restore the production of saliva and tears in animals from which healthy salivary or lacrimal glands had previously been excised. TUS’s Takashi Tsuji and colleagues reported their results in two papers published today (October 1) in Nature Communications.

“People have done a lot of work with stem cells, but this is the first time I’ve seen transplantation of a whole [bioengineered] salivary gland,” said the University of Buffalo’s Olga Baker, an assistant professor of oral biology, who was not involved in the work. “To my knowledge, this is a first.”

Dysfunction of the salivary and tear glands are associated with a variety of diseases, and can cause additional complications. Patients with an autoimmune disease called Sjogren’s syndrome, for example, typically experience both dry eyes and mouth. If researchers were able to engineer working replacement glands for humans, they could restore at least some of the lost function in people with this and other diseases.

To create the secretory glands, Tsuji and his colleagues ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies